PMV Pharma issues warrants to buy 41,955,000 shares in $50.8 million offering

PMV Pharmaceuticals priced a $50.8 million public offering featuring accompanying warrants to buy 41,955,000 common shares.

• Accompanying warrants carry an initial exercise price of $1.21 per share, are immediately exercisable, and expire five years from issuance.
• The offering includes 22,055,000 common shares and pre-funded warrants for up to 19,900,000 shares, with each sold together with one accompanying warrant.